Edition:
United Kingdom

Cosmo Pharmaceuticals NV (COPN.S)

COPN.S on Swiss Exchange

102.00CHF
9:52am GMT
Change (% chg)

CHF-1.70 (-1.64%)
Prev Close
CHF103.70
Open
CHF103.30
Day's High
CHF103.60
Day's Low
CHF101.50
Volume
3,206
Avg. Vol
18,118
52-wk High
CHF150.70
52-wk Low
CHF99.50

Select another date:

Wed, Nov 28 2018

BRIEF-Cosmo Pharmaceuticals: FDA Grants Approval For Aemcolo (Tm) (Rifamycin)

* FDA GRANTS APPROVAL FOR AEMCOLO (TM) (RIFAMYCIN), THE FIRST APPROVED ANTIBIOTIC TO TREAT TRAVELER'S DIARRHEA FOR TEN YEARS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Cassiopea Enters Into Loan Agreement With Cosmo Pharmaceuticals

* COSMO PHARMACEUTICALS HAS OFFERED AN UNSECURED CREDIT LINE OF EUR 10 MILLION THAT CAN BE INCREASED TO EUR 20 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Cosmo Pharmaceuticals Updates On Type A Meeting Outcome For MB MMX

* METHYLENE BLUE MMX REGULATORY UPDATE: TYPE A MEETING OUTCOME

BRIEF-Cosmo Pharmaceuticals H1 Revenue Up 15.2 Pct To EUR 36.7 Million

* H1 REVENUE UP 15.2% TO EUR36.7M DRIVEN BY UP-FRONT LICENSE FEESÂ

Select another date: